Cargando…

Tight Blood Pressure Control in Chronic Kidney Disease

Hypertension affects over a billion people worldwide and is the leading cause of cardiovascular disease and premature death worldwide, as well as one of the key determinants of chronic kidney disease worldwide. People with chronic kidney disease and hypertension are at very high risk of renal outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentile, Giorgio, Mckinney, Kathryn, Reboldi, Gianpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144041/
https://www.ncbi.nlm.nih.gov/pubmed/35621850
http://dx.doi.org/10.3390/jcdd9050139
_version_ 1784715952170991616
author Gentile, Giorgio
Mckinney, Kathryn
Reboldi, Gianpaolo
author_facet Gentile, Giorgio
Mckinney, Kathryn
Reboldi, Gianpaolo
author_sort Gentile, Giorgio
collection PubMed
description Hypertension affects over a billion people worldwide and is the leading cause of cardiovascular disease and premature death worldwide, as well as one of the key determinants of chronic kidney disease worldwide. People with chronic kidney disease and hypertension are at very high risk of renal outcomes, including progression to end-stage renal disease, and, even more importantly, cardiovascular outcomes. Hence, blood pressure control is crucial in reducing the human and socio-economic burden of renal and cardiovascular outcomes in those patients. However, current guidelines from hypertension and renal societies have issued different and sometimes conflicting recommendations, which risk confusing clinicians and potentially contributing to a less effective prevention of renal and cardiovascular outcomes. In this review, we critically appraise existing evidence and key international guidelines, and we finally formulate our own opinion that clinicians should aim for a blood pressure target lower than 130/80 in all patients with chronic kidney disease and hypertension, unless they are frail or with multiple comorbidities. We also advocate for an even more ambitious systolic blood pressure target lower than 120 mmHg in younger patients with a lower burden of comorbidities, to minimise their risk of renal and cardiovascular events during their lifetime.
format Online
Article
Text
id pubmed-9144041
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91440412022-05-29 Tight Blood Pressure Control in Chronic Kidney Disease Gentile, Giorgio Mckinney, Kathryn Reboldi, Gianpaolo J Cardiovasc Dev Dis Review Hypertension affects over a billion people worldwide and is the leading cause of cardiovascular disease and premature death worldwide, as well as one of the key determinants of chronic kidney disease worldwide. People with chronic kidney disease and hypertension are at very high risk of renal outcomes, including progression to end-stage renal disease, and, even more importantly, cardiovascular outcomes. Hence, blood pressure control is crucial in reducing the human and socio-economic burden of renal and cardiovascular outcomes in those patients. However, current guidelines from hypertension and renal societies have issued different and sometimes conflicting recommendations, which risk confusing clinicians and potentially contributing to a less effective prevention of renal and cardiovascular outcomes. In this review, we critically appraise existing evidence and key international guidelines, and we finally formulate our own opinion that clinicians should aim for a blood pressure target lower than 130/80 in all patients with chronic kidney disease and hypertension, unless they are frail or with multiple comorbidities. We also advocate for an even more ambitious systolic blood pressure target lower than 120 mmHg in younger patients with a lower burden of comorbidities, to minimise their risk of renal and cardiovascular events during their lifetime. MDPI 2022-04-30 /pmc/articles/PMC9144041/ /pubmed/35621850 http://dx.doi.org/10.3390/jcdd9050139 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gentile, Giorgio
Mckinney, Kathryn
Reboldi, Gianpaolo
Tight Blood Pressure Control in Chronic Kidney Disease
title Tight Blood Pressure Control in Chronic Kidney Disease
title_full Tight Blood Pressure Control in Chronic Kidney Disease
title_fullStr Tight Blood Pressure Control in Chronic Kidney Disease
title_full_unstemmed Tight Blood Pressure Control in Chronic Kidney Disease
title_short Tight Blood Pressure Control in Chronic Kidney Disease
title_sort tight blood pressure control in chronic kidney disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144041/
https://www.ncbi.nlm.nih.gov/pubmed/35621850
http://dx.doi.org/10.3390/jcdd9050139
work_keys_str_mv AT gentilegiorgio tightbloodpressurecontrolinchronickidneydisease
AT mckinneykathryn tightbloodpressurecontrolinchronickidneydisease
AT reboldigianpaolo tightbloodpressurecontrolinchronickidneydisease